A previously unrecognized protein-protein interaction between TWEAK and CD163: Potential biological implications

Laura C. Bover, Marina Cardó-Vila, Akihiko Kuniyasu, Jessica Sun, Roberto Rangel, Motohiro Takeya, Bharat B. Aggarwal, Wadih Arap, Renata Pasqualini

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

TWEAK (TNF-like weak inducer of apoptosis) is a TNF superfamily member implicated in several mechanisms. Although fibroblast growth factor inducible 14 (Fn14)/TweakR has been reported as its receptor, an as yet unrecognized surface molecule(s) might modulate TWEAK function(s). Thus, we set out to identify TWEAK-binding proteins by screening a combinatorial peptide library. Cyclic peptides containing a consensus motif (WXDDG) bound to TWEAK specifically. These peptides were similar to CD163, a scavenger receptor cysteine-rich domain family member, restricted to the monocyte/ macrophage lineage and responsible for the uptake of circulating haptoglobin-hemoglobin (Hp-Hb) complexes. Sequence profile analysis suggested that TWEAK mimicked the CD163 natural ligand (Hp-Hb). Consistently, we show dose-dependent TWEAK binding to CD163 and blockade by an anti-CD163 Ab. In a competition assay, both soluble CD163 and Fn14/ TweakR were able to compete off TWEAK binding to coated Fn14/TweakR or CD163, respectively. Flow-cytometry and immunofluorescence assays showed that human monocytes (Fn14/TweakR negative and CD163 positive) bind TWEAK, thus blocking the recognition of CD163 and reducing the activation mediated by a specific mAb in these cells. We demonstrate that monocytes can sequester TWEAK from supernatants, thus preventing tumor cell apoptosis; this effect was reverted by preincubation with the peptide mimicking CD163 or with a mAb anti-CD163, indicating specificity. Finally, we show that recombinant human TWEAK binding to CD163-transfected Chinese hamster ovary cells is inhibited by the presence of either unlabeled TWEAK or the Hp-Hb complex. Together, these data are consistent with the hypothesis that CD163 either acts as a TWEAK scavenger in pathological conditions or serves as an alternate receptor for TWEAK in cells lacking Fn14/TweakR.

Original languageEnglish (US)
Pages (from-to)8183-8194
Number of pages12
JournalJournal of Immunology
Volume178
Issue number12
DOIs
StatePublished - Jun 15 2007
Externally publishedYes

Fingerprint

Monocytes
Proteins
Apoptosis
Peptide Library
Scavenger Receptors
Cyclic Peptides
Peptides
Haptoglobins
Cricetulus
Fluorescent Antibody Technique
Cysteine
Sequence Analysis
Ovary
Consensus
Carrier Proteins
Flow Cytometry
Hemoglobins
Macrophages
Ligands
Neoplasms

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Bover, Laura C. ; Cardó-Vila, Marina ; Kuniyasu, Akihiko ; Sun, Jessica ; Rangel, Roberto ; Takeya, Motohiro ; Aggarwal, Bharat B. ; Arap, Wadih ; Pasqualini, Renata. / A previously unrecognized protein-protein interaction between TWEAK and CD163 : Potential biological implications. In: Journal of Immunology. 2007 ; Vol. 178, No. 12. pp. 8183-8194.
@article{f209d0dd0665408986a558c33e79e24d,
title = "A previously unrecognized protein-protein interaction between TWEAK and CD163: Potential biological implications",
abstract = "TWEAK (TNF-like weak inducer of apoptosis) is a TNF superfamily member implicated in several mechanisms. Although fibroblast growth factor inducible 14 (Fn14)/TweakR has been reported as its receptor, an as yet unrecognized surface molecule(s) might modulate TWEAK function(s). Thus, we set out to identify TWEAK-binding proteins by screening a combinatorial peptide library. Cyclic peptides containing a consensus motif (WXDDG) bound to TWEAK specifically. These peptides were similar to CD163, a scavenger receptor cysteine-rich domain family member, restricted to the monocyte/ macrophage lineage and responsible for the uptake of circulating haptoglobin-hemoglobin (Hp-Hb) complexes. Sequence profile analysis suggested that TWEAK mimicked the CD163 natural ligand (Hp-Hb). Consistently, we show dose-dependent TWEAK binding to CD163 and blockade by an anti-CD163 Ab. In a competition assay, both soluble CD163 and Fn14/ TweakR were able to compete off TWEAK binding to coated Fn14/TweakR or CD163, respectively. Flow-cytometry and immunofluorescence assays showed that human monocytes (Fn14/TweakR negative and CD163 positive) bind TWEAK, thus blocking the recognition of CD163 and reducing the activation mediated by a specific mAb in these cells. We demonstrate that monocytes can sequester TWEAK from supernatants, thus preventing tumor cell apoptosis; this effect was reverted by preincubation with the peptide mimicking CD163 or with a mAb anti-CD163, indicating specificity. Finally, we show that recombinant human TWEAK binding to CD163-transfected Chinese hamster ovary cells is inhibited by the presence of either unlabeled TWEAK or the Hp-Hb complex. Together, these data are consistent with the hypothesis that CD163 either acts as a TWEAK scavenger in pathological conditions or serves as an alternate receptor for TWEAK in cells lacking Fn14/TweakR.",
author = "Bover, {Laura C.} and Marina Card{\'o}-Vila and Akihiko Kuniyasu and Jessica Sun and Roberto Rangel and Motohiro Takeya and Aggarwal, {Bharat B.} and Wadih Arap and Renata Pasqualini",
year = "2007",
month = "6",
day = "15",
doi = "10.4049/jimmunol.178.12.8183",
language = "English (US)",
volume = "178",
pages = "8183--8194",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

A previously unrecognized protein-protein interaction between TWEAK and CD163 : Potential biological implications. / Bover, Laura C.; Cardó-Vila, Marina; Kuniyasu, Akihiko; Sun, Jessica; Rangel, Roberto; Takeya, Motohiro; Aggarwal, Bharat B.; Arap, Wadih; Pasqualini, Renata.

In: Journal of Immunology, Vol. 178, No. 12, 15.06.2007, p. 8183-8194.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A previously unrecognized protein-protein interaction between TWEAK and CD163

T2 - Potential biological implications

AU - Bover, Laura C.

AU - Cardó-Vila, Marina

AU - Kuniyasu, Akihiko

AU - Sun, Jessica

AU - Rangel, Roberto

AU - Takeya, Motohiro

AU - Aggarwal, Bharat B.

AU - Arap, Wadih

AU - Pasqualini, Renata

PY - 2007/6/15

Y1 - 2007/6/15

N2 - TWEAK (TNF-like weak inducer of apoptosis) is a TNF superfamily member implicated in several mechanisms. Although fibroblast growth factor inducible 14 (Fn14)/TweakR has been reported as its receptor, an as yet unrecognized surface molecule(s) might modulate TWEAK function(s). Thus, we set out to identify TWEAK-binding proteins by screening a combinatorial peptide library. Cyclic peptides containing a consensus motif (WXDDG) bound to TWEAK specifically. These peptides were similar to CD163, a scavenger receptor cysteine-rich domain family member, restricted to the monocyte/ macrophage lineage and responsible for the uptake of circulating haptoglobin-hemoglobin (Hp-Hb) complexes. Sequence profile analysis suggested that TWEAK mimicked the CD163 natural ligand (Hp-Hb). Consistently, we show dose-dependent TWEAK binding to CD163 and blockade by an anti-CD163 Ab. In a competition assay, both soluble CD163 and Fn14/ TweakR were able to compete off TWEAK binding to coated Fn14/TweakR or CD163, respectively. Flow-cytometry and immunofluorescence assays showed that human monocytes (Fn14/TweakR negative and CD163 positive) bind TWEAK, thus blocking the recognition of CD163 and reducing the activation mediated by a specific mAb in these cells. We demonstrate that monocytes can sequester TWEAK from supernatants, thus preventing tumor cell apoptosis; this effect was reverted by preincubation with the peptide mimicking CD163 or with a mAb anti-CD163, indicating specificity. Finally, we show that recombinant human TWEAK binding to CD163-transfected Chinese hamster ovary cells is inhibited by the presence of either unlabeled TWEAK or the Hp-Hb complex. Together, these data are consistent with the hypothesis that CD163 either acts as a TWEAK scavenger in pathological conditions or serves as an alternate receptor for TWEAK in cells lacking Fn14/TweakR.

AB - TWEAK (TNF-like weak inducer of apoptosis) is a TNF superfamily member implicated in several mechanisms. Although fibroblast growth factor inducible 14 (Fn14)/TweakR has been reported as its receptor, an as yet unrecognized surface molecule(s) might modulate TWEAK function(s). Thus, we set out to identify TWEAK-binding proteins by screening a combinatorial peptide library. Cyclic peptides containing a consensus motif (WXDDG) bound to TWEAK specifically. These peptides were similar to CD163, a scavenger receptor cysteine-rich domain family member, restricted to the monocyte/ macrophage lineage and responsible for the uptake of circulating haptoglobin-hemoglobin (Hp-Hb) complexes. Sequence profile analysis suggested that TWEAK mimicked the CD163 natural ligand (Hp-Hb). Consistently, we show dose-dependent TWEAK binding to CD163 and blockade by an anti-CD163 Ab. In a competition assay, both soluble CD163 and Fn14/ TweakR were able to compete off TWEAK binding to coated Fn14/TweakR or CD163, respectively. Flow-cytometry and immunofluorescence assays showed that human monocytes (Fn14/TweakR negative and CD163 positive) bind TWEAK, thus blocking the recognition of CD163 and reducing the activation mediated by a specific mAb in these cells. We demonstrate that monocytes can sequester TWEAK from supernatants, thus preventing tumor cell apoptosis; this effect was reverted by preincubation with the peptide mimicking CD163 or with a mAb anti-CD163, indicating specificity. Finally, we show that recombinant human TWEAK binding to CD163-transfected Chinese hamster ovary cells is inhibited by the presence of either unlabeled TWEAK or the Hp-Hb complex. Together, these data are consistent with the hypothesis that CD163 either acts as a TWEAK scavenger in pathological conditions or serves as an alternate receptor for TWEAK in cells lacking Fn14/TweakR.

UR - http://www.scopus.com/inward/record.url?scp=34250211507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250211507&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.178.12.8183

DO - 10.4049/jimmunol.178.12.8183

M3 - Article

C2 - 17548657

AN - SCOPUS:34250211507

VL - 178

SP - 8183

EP - 8194

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -